Afghanistan vs Turkmenistan: Hepatitis B surface antigen (HBsAg) prevalence
Afghanistan
0.3%
in 2024
Turkmenistan
0.3%
in 2024
Afghanistan rank
71st
Turkmenistan rank
71st
Hepatitis B surface antigen (HBsAg) prevalence over time
- Afghanistan
- Turkmenistan
How they compare
Afghanistan currently reports 0.3% against 0.3% in Turkmenistan, a difference of 0.0%.
Across all 10 years both countries report, Turkmenistan has been ahead every year.
Afghanistan ranks 71st and Turkmenistan ranks 71st of 194 countries.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.4% | 0.1% | Turkmenistan |
| 2020s | 0.3% | 0.3% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Afghanistan or Turkmenistan?
- Afghanistan, at 0.3% against 0.3% in Turkmenistan as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Afghanistan and Turkmenistan?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Turkmenistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Afghanistan and Turkmenistan rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Afghanistan ranks 71st and Turkmenistan ranks 71st of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.